1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Kronos Bio, Inc.
  6. Consensus
    KRON   US50107A1043

KRONOS BIO, INC.

(KRON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on KRONOS BIO, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) KRONOS BIO, INC.
Analyst Recommendations on KRONOS BIO, INC.
02/28Piper Sandler Adjusts Kronos Bio's Price Target to $30 From $50, Reiterates Overweight Rat..
MT
2021KRONOS BIO : HC Wainwright Starts Kronos Bio at Buy With $35 Price Target
MT
2020KRONOS BIO : Jefferies Starts Kronos Bio at Buy With $36 Price Target
MT
2020KRONOS BIO : Piper Sandler Starts Kronos Bio at Overweight With $50 Price Target
MT
2020KRONOS BIO : Goldman Sachs Starts Kronos Bio at Buy With $45 Price Target
MT
2020KRONOS BIO : Cowen Initiates Coverage on Kronos Bio With Outperform Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,76 $
Average target price 29,50 $
Spread / Average Target 685%
High Price Target 36,00 $
Spread / Highest target 857%
Low Price Target 17,00 $
Spread / Lowest Target 352%
Consensus detail
Consensus revision (last 18 months)